These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2525576)

  • 1. Onset of response in relation to outcome in depressed outpatients with placebo and imipramine.
    Khan A; Cohen S; Dager S; Avery DH; Dunner DL
    J Affect Disord; 1989; 17(1):33-8. PubMed ID: 2525576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
    Lydiard RB; Laird LK; Morton WA; Steele TE; Kellner C; Laraia MT; Ballenger JC
    Psychopharmacol Bull; 1989; 25(1):68-70. PubMed ID: 2505304
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
    Norton KR; Sireling LI; Bhat AV; Rao B; Paykel ES
    J Affect Disord; 1984 Dec; 7(3-4):297-308. PubMed ID: 6241211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
    Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
    Wakelin JS
    Int Clin Psychopharmacol; 1986 Jul; 1(3):221-30. PubMed ID: 3104446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine and imipramine: results of a long-term controlled trial.
    Guelfi JD; Dreyfus JF; Pichot P
    Int Clin Psychopharmacol; 1987 Apr; 2(2):103-9. PubMed ID: 3110264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J; Schless AP
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD; Browne M; Horn E; Oyewumi LK; Sarantidis D; Roberts N; Badoe K; Tessier P
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of alprazolam, imipramine, and placebo in the treatment of depression.
    Feighner JP; Aden GC; Fabre LF; Rickels K; Smith WT
    JAMA; 1983 Jun; 249(22):3057-64. PubMed ID: 6133970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
    Feighner JP; Meredith CH; Frost NR; Chammas S; Hendrickson G
    Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

  • 18. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Byerley WF; Reimherr FW; Wood DR; Grosser BI
    J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.
    Laird LK; Lydiard RB; Morton WA; Steele TE; Kellner C; Thompson NM; Ballenger JC
    J Clin Psychiatry; 1993 Jun; 54(6):224-8. PubMed ID: 8331091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.